Navigation Links
Aspirin recommendations changed for many younger diabetic patients
Date:6/1/2010

CORVALLIS, Ore. Experts are now recommending that low-dose aspirin therapy to prevent heart attacks be used somewhat more conservatively that men younger than 50 and women younger than 60, who have diabetes but no other major risk factors, probably not use aspirin.

The new recommendations are based on an analysis of nine studies, which found that the risks of some side effects such as stomach bleeding, and to a much less extent bleeding strokes, have to be better balanced against the potential benefits of using aspirin.

The findings are agreed upon by a panel of experts and endorsed by the American Diabetes Association, the American Heart Association and the American College of Cardiology Foundation. They were just published online as a position statement in the journal Diabetes Care.

"The larger theme here is that use of low-dose aspirin to prevent heart attacks in people who have not already experienced one is probably not as efficacious as we used to believe it was," said Craig Williams, an associate professor in the College of Pharmacy at Oregon State University, and one of the experts on the recent review panel.

"With any medication, you have to balance the benefits against possible side effects or risks," Williams said. "But even a baby aspirin has some degree of risk, even though it's very low, so we have to be able to show clear benefits that outweigh that risk. In the case of young adults with diabetes but no other significant risk factors, it's not clear that the benefits are adequate to merit use of aspirin."

Aspirin first came to attention for its clear value in acute situations, or people experiencing a heart attack and immediately taking an aspirin. Later it was believed that regular low-doses of aspirin, which act as an anti-coagulant or blood thinner, may have value for people who have risk factors for heart disease, such as high blood pressure, smoking, a family history of cardiovascular disease, or other relevant health issues.

Diabetics also face higher risk of heart disease as they age, and it had been recommended by many doctors that diabetics use low-dose aspirin therapy along with their other medications. The newest recommendations suggest that aspirin be used only by diabetics who have other risk factors and are older men older than 50 and women older than 60. A recent update to the U.S. Preventive Services Task Force is still recommending aspirin use for older adults who are not diabetics ages 45-79 for men, 55-79 for women and who have other risk factors.

"The newest studies just weren't showing adequate benefits for some younger diabetics," Williams said.

At least part of the issue, Williams said, is that widespread use of drugs to control blood pressure and reduce cholesterol has lessened the additional benefits of aspirin. For people who have high blood pressure or elevated cholesterol and are not taking appropriate medications to address those problems, aspirin use might be more justified, Williams said. However, generic statin medications for cholesterol and various hypertension treatments are now available at minimal costs, he said, and have to be considered as part of the optimal approach.

Williams said there is no evidence that higher doses of aspirin beyond the range of 75-162 milligrams per day have any added value in preventing heart attacks. An adequate level of protection is generally achieved with what's considered a "baby aspirin," usually sold in the U.S. as a pill of 81 milligrams, or one-fourth the strength of a typical 325 milligram single aspirin pill.

Additional studies in patients with diabetes are being conducted to further demonstrate exactly who would best benefit from aspirin therapy, Williams said.


'/>"/>

Contact: Craig Williams
williacr@ohsu.edu
503-494-1598
Oregon State University
Source:Eurekalert

Related medicine news :

1. Experts Advise At-Risk Diabetics to Begin Daily Aspirin Later
2. Aspirin May Increase Risk of Crohns Disease
3. Aspirin Alone Works Best to Prevent Clots a Year After Stenting
4. Cardiologists Comment on Aspirin Versus Resveratrol
5. Aspirin May Boost Breast Cancer Survival
6. Aspirin During Pregnancy May Help Preemies
7. Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages
8. In Women, Aspirin Might Ward Off Eye Trouble
9. ACR task force makes recommendations for improving relationships between radiologists and hospitals
10. G8 to receive recommendations on women and childrens health
11. SIUE Pain Summit Recommendations Announced Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... The Bryant Agency, ... families and business owners in the Dalton region, is working in conjunction with ... sexual assault and physical abuse. , The GreenHouse is headquartered in Dalton and ...
(Date:7/21/2017)... ... July 21, 2017 , ... Adolfson ... renovate and improve the Ramsey County Medical Examiners Facility located in Saint Paul, ... $2.5 million project is scheduled to start in late 2017/early 2018. , ...
(Date:7/21/2017)... ... , ... The Margarian Law Firm has filed a class action lawsuit ... allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” brand of ginger ale ... Canada Dry Ginger Ale claims on its bottle that it is made from real ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... EyeMist®, the signature product of her research center at Bio-Logic Aqua Research® Water ... population and the greatest number of sufferers of blindness. “We think that Nature’s ...
(Date:7/20/2017)... ... 2017 , ... TransPixel Volume 2 is a set of transitions that create ... effect isolates horizontal and vertical lines of pixels and sorts their pixels by darkness, ... animation and can be changed using a drop-down menu. Create amazing and artistic transitions ...
Breaking Medicine News(10 mins):
(Date:7/20/2017)... PAUL, Minn. , July 20, 2017  Prime Therapeutics ... Jonathan Gavras , M.D., following today,s Institute for Clinical ... report on the effectiveness and value of abuse-deterrent ... manager on the policy roundtable at the meeting. ... is not a material cost benefit to the use of ...
(Date:7/15/2017)... 2017 Enterin Inc., a Philadelphia ... (PD), today announced the completion of a $12.7 million Series ... III, as well as the participation of existing investors. ... have the support of New Ventures III and our current ... of the potential of our platform technology to transform the ...
(Date:7/13/2017)... WILLIAMSTON, Mich. , July 13, 2017  Centurion Medical Products, ... offers its DisImpactor ® fecal impaction removal device for hospice ... ... Patient pain management ... DisImpactor for Hospice can help alleviate patient pain while preventing unneeded ...
Breaking Medicine Technology: